Pfizer posts surprise 4th quarter profit, but key products miss on sales
Cour gets $105M, pharma help to ‘reprogram’ autoimmune diseases
US bill paints some Chinese biotechs as security threats
Non-opioid drug from Vertex cuts pain in major trial tests
